You are seeing these quotes based on previous browsing related to sectors such as
Latest | Forecast | |
---|---|---|
Div Yield | n/a | 0.0% |
Div Cover | n/a | n/a |
Op Mrgn | n/a | -9.9% |
ROCE | n/a |
Latest | Forecast | |
---|---|---|
P/E | n/a | 0.0 |
PEG | n/a | -999,999.0 |
Price / Revenue | n/a | 32.1 |
Price / Book value | n/a |
Latest | Forecast | |
---|---|---|
Revenue | 0.0% | 0.0% |
PBT | 0.0% | n/a |
EPS | 0.0% | 0.0% |
DPS | 0.0% | 0.0% |
Year Ending | Revenue ($m) |
Pre-tax ($m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
---|---|---|---|---|---|---|---|---|
2016-12-31 | 12.27 | -3.35 | $-0.11 | -15.4 | 0.0 | n/a | n/a | 0.0% |
2017-12-31 | 13.98 | -9.92 | $-0.20 | -16.3 | 0.0 | n/a | n/a | 0.0% |
2018-12-31 | 16.67 | -8.87 | $-0.17 | -14.2 | 0.0 | n/a | n/a | 0.0% |
2019-12-31 | 21.62 | -12.89 | $-0.23 | -7.2 | 0.0 | n/a | n/a | 0.0% |
MaxCyte raises £40m from new and existing investors Sharecast News | 04 Feb |
---|---|
MaxCyte revenue growth expected to accelerate faster than anticipated Sharecast News | 20 Jan |
MaxCyte appoints Amanda Murphy as CFO Sharecast News | 09 Sep |
Participation in Upcoming Investor Conferences | 23-Feb-21 07:00 |
---|---|
Director Dealings and Issue of Equity | 19-Feb-21 07:00 |
Grant of Options | 17-Feb-21 17:45 |
Holding(s) in Company | 15-Feb-21 16:33 |
Holding(s) in Company | 12-Feb-21 13:59 |